Second study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify ...
Detailed price information for Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP-Q) from The Globe and Mail including charting and trades.
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating ...
Polestar (the "Company") today announces that it plans to change the ratio of its Class A, Class B, Class C-1 and Class C-2 American Depositary Shares (collectively, the "ADSs") to the respective ...
Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.
Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ...
Multiple Late-Stage Data Readouts Reinforce Telitacicept’s Broad Potential Across Autoimmune DiseasesExpansion of Executive Leadership and Board ...
Alfredo Juarez Zeferino, known as Lelo, is a Mexican farmworker and co-founder of Familias Unidas por la Justicia, an ...
More Americans are turning to peptides for muscle building, skin rejuvenation, and to try and live longer even though the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback